Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.010
-0.040 (-3.81%)
At close: Dec 20, 2024, 4:00 PM
0.970
-0.040 (-3.96%)
After-hours: Dec 20, 2024, 7:57 PM EST
Bone Biologics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Bone Biologics.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Bone Biologics.
Recommendation Trends
| Rating | Jan '23 | Feb '23 | Mar '23 | Apr '23 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| EF Hutton | EF Hutton | Strong Buy Reiterates $540 | Strong Buy | Reiterates | $540 | +53,365.35% | Apr 13, 2023 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $540 | Strong Buy | Reiterates | $540 | +53,365.35% | Apr 3, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates $540 | Strong Buy | Initiates | $540 | +53,365.35% | Oct 18, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.10
from -34.01
EPS Next Year
-1.99
from -5.10
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -5.25 | -2.05 | -2.07 |
| Avg | -5.10 | -1.99 | -2.01 |
| Low | -4.90 | -1.91 | -1.93 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.